TP53 and neoplasm: In TP53 wild-type tumours, D-type cyclin and p21 expression did not generally correlate with either genome-doubling (supplementary Figure S6, available at Annals of Oncology online) or with genome stability (supplementary Figure S7, available at Annals of Oncology online), as measured by wGII score [9].